These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 19761553)
1. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy. Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553 [TBL] [Abstract][Full Text] [Related]
2. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657 [TBL] [Abstract][Full Text] [Related]
3. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925 [TBL] [Abstract][Full Text] [Related]
4. Recurrent IgA nephropathy in renal transplant allografts. Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693 [TBL] [Abstract][Full Text] [Related]
5. The fate of renal transplants in patients with IgA nephropathy. Frohnert PP; Donadio JV; Velosa JA; Holley KE; Sterioff S Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449 [TBL] [Abstract][Full Text] [Related]
6. Single-center long-term results of renal transplantation for IgA nephropathy. Bumgardner GL; Amend WC; Ascher NL; Vincenti FG Transplantation; 1998 Apr; 65(8):1053-60. PubMed ID: 9583865 [TBL] [Abstract][Full Text] [Related]
7. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168 [TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589 [TBL] [Abstract][Full Text] [Related]
9. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy. Ng YS; Vathsala A; Chew ST; Chiang GS; Woo KT Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation. Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321 [TBL] [Abstract][Full Text] [Related]
11. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. McDonald SP; Russ GR Transplantation; 2006 Sep; 82(6):759-62. PubMed ID: 17006322 [TBL] [Abstract][Full Text] [Related]
13. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Courtney AE; McNamee PT; Nelson WE; Maxwell AP Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729 [TBL] [Abstract][Full Text] [Related]
14. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival. Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512 [TBL] [Abstract][Full Text] [Related]
15. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461 [TBL] [Abstract][Full Text] [Related]
16. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Kim YS; Moon JI; Jeong HJ; Kim MS; Kim SI; Choi KH; Lee HY; Han DS; Park K Transplantation; 2001 Jan; 71(2):233-8. PubMed ID: 11213065 [TBL] [Abstract][Full Text] [Related]
17. Renal transplantation in patients with primary immunoglobulin A nephropathy. Choy BY; Chan TM; Lo SK; Lo WK; Lai KN Nephrol Dial Transplant; 2003 Nov; 18(11):2399-404. PubMed ID: 14551373 [TBL] [Abstract][Full Text] [Related]
18. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. Bantis C; Heering PJ; Aker S; Schwandt C; Grabensee B; Ivens K J Nephrol; 2008; 21(6):941-6. PubMed ID: 19034880 [TBL] [Abstract][Full Text] [Related]
19. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation]. Matsugami K; Naito T; Nitta K; Nihei H; Tanabe K; Toma H; Yamaguchi Y Nihon Jinzo Gakkai Shi; 1998 Jul; 40(5):322-8. PubMed ID: 9752688 [TBL] [Abstract][Full Text] [Related]
20. Higher Incidence of Renal Allograft Glomerulonephritis in Living-Related Donor Kidney Transplantation. Deng R; Dai Y; Zhang H; Liu L; Li J; Xiong Y; Deng S; Fu Q; Wang C Transplant Proc; 2018 Oct; 50(8):2421-2425. PubMed ID: 30316370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]